Iba T, Yagi Y, Kidokoro A, Fukunaga M, Fukunaga T, Mishima S
Dept. of Surgery, Urayasu Hospital.
Gan To Kagaku Ryoho. 1993 Dec;20(15):2383-5.
Four cases of unresectable adenocarcinoma due to multiple metastasis were treated by EAP (etoposide, ADM, CDDP). The first was a 49-year-old male with gall bladder cancer, who was admitted to the hospital with metastatic umbilical tumor and intraabdominal dissemination. After 2 courses of treatment, the tumor was significantly decreased and the dissemination was diminished. The second was a 42-year-old female of breast cancer, involving lung, adrenal gland and bone metastasis. After 2 courses of treatment, all metastasis responded remarkably. Case 3 was a 42-year-old female with recurrent rectal cancer. Her lung metastasis completely disappeared after EAP treatment. Case 4 was a 42-year-old breast cancer patient with multiple liver metastasis, who also exhibited a remarkable response. In spite of severe side effects, EAP treatment was remarkably effective in all four cases of unresectable advanced adenocarcinoma.
4例因多发转移而无法切除的腺癌患者接受了EAP(依托泊苷、阿霉素、顺铂)治疗。第一例是一名49岁的胆囊癌男性患者,因转移性脐部肿瘤和腹腔内播散入院。经过2个疗程的治疗,肿瘤明显缩小,播散减轻。第二例是一名42岁的乳腺癌女性患者,伴有肺、肾上腺和骨转移。经过2个疗程的治疗,所有转移灶均有显著反应。病例3是一名42岁的复发性直肠癌女性患者。EAP治疗后,她的肺转移完全消失。病例4是一名42岁的乳腺癌患者,有多处肝转移,也表现出显著反应。尽管有严重的副作用,但EAP治疗对所有4例无法切除的晚期腺癌均非常有效。